Recombinant Human Follitropin for Injection (GeneScience Pharmaceuticals)

注射用重组人促卵泡激素（金赛药业）

Report date: 2025/08/04 15:47:53

Base Information

Drug NameRecombinant Human Follitropin for Injection (GeneScience Pharmaceuticals)
Drug Alias Name重组人促卵泡激素注射液（金赛药业）r-FSH(GeneScience Pharmaceuticals)Recombinant Human Follitropin (GeneScience Pharmaceuticals)金赛恒Genesci-008
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionFollicle-stimulating hormone receptor agonistsOvarian follicle stimulants
TargetsFollicle-stimulating hormone receptor
Therapy Area/IndicationsInfertility, Female
Global Approved IndicationsInfertility, Female
Approved Indications in ChinaInfertility, Female
Original Approved Country/TerritoryMainland China
Original Approved Date2015/05/27
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesChangchun GeneScience Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChangchun GeneScience Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsInfertility, Female
Inactive IndicationsN/A

Other Information

ATC CodeG03GA05G03GA06G03GA10
Related LinksN/A